| Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/β-secretase expression SS Hébert, K Horré, L Nicolaï, AS Papadopoulou, W Mandemakers, ... Proceedings of the National Academy of Sciences 105 (17), 6415-6420, 2008 | 1492 | 2008 |
| Alteration of the micro RNA network during the progression of Alzheimer's disease P Lau, K Bossers, R Janky, E Salta, CS Frigerio, S Barbash, R Rothman, ... EMBO molecular medicine 5 (10), 1613-1634, 2013 | 553 | 2013 |
| MicroRNA regulation of Alzheimer's Amyloid precursor protein expression SS Hébert, K Horré, L Nicolaï, B Bergmans, AS Papadopoulou, ... Neurobiology of disease 33 (3), 422-428, 2009 | 542 | 2009 |
| Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegeneration SS Hébert, AS Papadopoulou, P Smith, MC Galas, E Planel, ... Human molecular genetics 19 (20), 3959-3969, 2010 | 394 | 2010 |
| Cardiac myocyte miR-29 promotes pathological remodeling of the heart by activating Wnt signaling Y Sassi, P Avramopoulos, D Ramanujam, L Grüter, S Werfel, S Giosele, ... Nature communications 8 (1), 1-11, 2017 | 253 | 2017 |
| The thymic epithelial microRNA network elevates the threshold for infection-associated thymic involution via miR-29a mediated suppression of the IFN-α receptor AS Papadopoulou, J Dooley, MA Linterman, W Pierson, O Ucar, ... Nature immunology 13 (2), 181-187, 2012 | 209 | 2012 |
| The microRNA-29 family dictates the balance between homeostatic and pathological glucose handling in diabetes and obesity J Dooley, JE Garcia-Perez, J Sreenivasan, SM Schlenner, ... Diabetes 65 (1), 53-61, 2016 | 176 | 2016 |
| MicroRNA-29 in the adaptive immune system: setting the threshold A Liston, AS Papadopoulou, D Danso-Abeam, J Dooley Cellular and Molecular Life Sciences 69 (21), 3533-3541, 2012 | 128 | 2012 |
| Deficiency of the miR-29a/b-1 cluster leads to ataxic features and cerebellar alterations in mice AS Papadopoulou, L Serneels, T Achsel, W Mandemakers, ... Neurobiology of disease 73, 275-288, 2015 | 66 | 2015 |
| Disruption to schizophrenia-associated gene Fez1 in the hippocampus of HDAC11 knockout mice DT Bryant, C Landles, AS Papadopoulou, AC Benjamin, JK Duckworth, ... Scientific Reports 7 (1), 11900, 2017 | 33 | 2017 |
| Extensive Expression Analysis of Htt Transcripts in Brain Regions from the zQ175 HD Mouse Model Using a QuantiGene Multiplex Assay AS Papadopoulou, C Gomez-Paredes, MA Mason, BA Taxy, D Howland, ... Scientific reports 9 (1), 16137, 2019 | 28 | 2019 |
| Silencing Srsf6 does not modulate incomplete splicing of the huntingtin gene in Huntington’s disease models MA Mason, C Gomez-Paredes, K Sathasivam, A Neueder, ... Scientific Reports 10 (1), 14057, 2020 | 27 | 2020 |
| The heat shock response, determined by QuantiGene multiplex, is impaired in HD mouse models and not caused by HSF1 reduction C Gomez-Paredes, MA Mason, BA Taxy, AS Papadopoulou, P Paganetti, ... Scientific reports 11 (1), 9117, 2021 | 9 | 2021 |
| Lowering the HTT1a transcript as an effective therapy for Huntington’s disease AS Papadopoulou, J Alterman, C Landles, EJ Smith, F Conroy, J Phillips, ... bioRxiv, 2025.06. 10.658804, 2025 | 2 | 2025 |
| microRNAs in sporadic Alzheimer’s disease and related dementias SS Hébert, W Mandemakers, AS Papadopoulou, B DeStrooper Macro roles for MicroRNAs in the life and death of neurons, 91-98, 2009 | 2 | 2009 |
| I006 Lowering htt1a with sirnas has more impact on early molecular and histological phenotypes than lowering full-length htt AS Papadopoulou, C Landles, EJ Smith, D O’Reilly, JF Alderman, ... Journal of Neurology, Neurosurgery & Psychiatry 95 (Suppl 1), A144-A144, 2024 | 1 | 2024 |
| B005 Characterisation of mouse embryonic fibroblast models of Huntington’s disease and their application as screening tools for therapeutic agents C Gomez-Paredes, K Sathasivam, AS Papadopoulou, S Fienko, ... Journal of Neurology, Neurosurgery & Psychiatry 95 (Suppl 1), A21-A21, 2024 | | 2024 |
| RNA-mediated pathogenic mechanisms in Huntington's disease GP Bates, S Fienko, C Landles, AS Papadopoulou Huntington's Disease, 135-158, 2024 | | 2024 |
| B19 Development of in vitro models to investigate the pathogenesis of huntington’s disease and screen for therapeutic agents AS Papadopoulou, K Sathasivam, L Blomer, SK Fienko, EJ Smith, ... Journal of Neurology, Neurosurgery & Psychiatry 89 (Suppl 1), A26-A26, 2018 | | 2018 |
| A18 Investigating the mechanisms of the heat shock response impairment in huntington’s disease CG Paredes, MA Mason, S McAteer, AS Papadopoulou, GP Bates Journal of Neurology, Neurosurgery & Psychiatry 89 (Suppl 1), A6-A7, 2018 | | 2018 |
